New York University Perlmutter Cancer Center ( Site 0008) — New York, New York

New York University Perlmutter Cancer Center ( Site 0008) is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

New York University Perlmutter Cancer Center ( Site 0008) has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Urinary Bladder Cancer, Muscle-invasive, Bladder Cancer.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York University Perlmutter Cancer Center ( Site 0008)?

New York University Perlmutter Cancer Center ( Site 0008) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York University Perlmutter Cancer Center ( Site 0008) conducted?

New York University Perlmutter Cancer Center ( Site 0008) has 2 clinical trials on record, with 2 currently active. Their work covers Urinary Bladder Cancer, Muscle-invasive, Bladder Cancer.

Is New York University Perlmutter Cancer Center ( Site 0008) accredited by Crixeo Health?

New York University Perlmutter Cancer Center ( Site 0008) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York University Perlmutter Cancer Center ( Site 0008)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.